Evaluation of the Relative Enhancement Ratio and Morphologic Findings on Biphasic CT to Differentiate Clear Cell and Non-Clear Cell Renal Cell Carcinoma
Nithida Na Songkhla, Mettaya Niamnarong, Kobkun Muangsomboon
Abstract
Nithida Na Songkhla, Mettaya Niamnarong, Kobkun Muangsomboon
Abstract
Objective: To differentiate clear cell and non-clear cell renal cell carcinoma (RCC) using enhancement pattern, relative enhancement ratio and associated findings on CT scan. Methods: This retrospective study reviewed CT scan in the unenhanced, corticomedullary and nephrographic phase in clear cell and non-clear cell RCC. A total of 49 patients with surgically proven RCC, consisting of 42 clear cell RCCs, and 7 non-clear cell RCCs (6 papillary, 1 chromophobe). Two radiologists compared degree of enhancement, enhancement pattern, the presence or absence of calcification, perinephric change, pelvocalyceal involvement, neovascularization, venous invasion, lymphadenopathy and distant metastasis. Results: Both the attenuation value and degree of enhancement in the corticomedullary phase were higher in clear cell RCC than non-clear cell RCC. The relative enhancement ratio in the corticomedullary phase was significantly higher in clear cell than non-clear cell RCC. The cutoff value of the relative enhancement ratio higher than 1.629 was used to differentiate clear cell RCC from non-clear cell RCC and had the sensitivity, specificity, PPV, NPV and accuracy of 76.2%, 85.7%, 97%, 37.5% and 77.6%, respectively. Heterogeneous enhancement, perinephric change and neovascularization were found significantly more common in clear cell than non-clear cell RCC. Conclusion: The most useful parameter to differentiate clear cell from non-clear cell RCC is relative enhance- ment ratio in the corticomedullary phase.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To differentiate clear cell and non-clear cell renal cell carcinoma (RCC) using enhancement pattern, relative enhancement ratio and associated findings on CT scan. Methods: This retrospective study reviewed CT scan in the unenhanced, corticomedullary and nephrographic phase in clear cell and non-clear cell RCC. A total of 49 patients with surgically proven RCC, consisting of 42 clear cell RCCs, and 7 non-clear cell RCCs (6 papillary, 1 chromophobe). Two radiologists compared degree of enhancement, enhancement pattern, the presence or absence of calcification, perinephric change, pelvocalyceal involvement, neovascularization, venous invasion, lymphadenopathy and distant metastasis. Results: Both the attenuation value and degree of enhancement in the corticomedullary phase were higher in clear cell RCC than non-clear cell RCC. The relative enhancement ratio in the corticomedullary phase was significantly higher in clear cell than non-clear cell RCC. The cutoff value of the relative enhancement ratio higher than 1.629 was used to differentiate clear cell RCC from non-clear cell RCC and had the sensitivity, specificity, PPV, NPV and accuracy of 76.2%, 85.7%, 97%, 37.5% and 77.6%, respectively. Heterogeneous enhancement, perinephric change and neovascularization were found significantly more common in clear cell than non-clear cell RCC. Conclusion: The most useful parameter to differentiate clear cell from non-clear cell RCC is relative enhance- ment ratio in the corticomedullary phase.
Key concepts: Clear cell, Chromophobe cell, Renal cell carcinoma, Clear cell renal cell carcinoma, Adipose capsule of kidney, Medicine, Cell, Clear cell carcinoma